Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Obada Ababneh"'
Autor:
Sakhr Alshwayyat, Ashaar Al-Akhras, Alina Ghazou, Tala Abdulsalam Alshwayyat, Obada Ababneh, Alia Alawneh
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract This study explored the role of radioiodine therapy (RAI) in low-risk thyroid cancer patients and examined the disease-specific survival (DSS) rates in a large cohort of differentiated thyroid cancer patients (DTC). We obtained patient data
Externí odkaz:
https://doaj.org/article/ae30de667a8c484d95c04f468c2cf56c
Autor:
Faris Jamal Abu Za'nouneh, Obada Ababneh, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, John D. Shaughnessy Jr, Fenghuang Zhan, Frits vanRhee, Samer Al Hadidi
Publikováno v:
eJHaem, Vol 4, Iss 2, Pp 454-458 (2023)
Abstract The definition of high‐risk multiple myeloma (HRMM) is evolving. Use of a clear definition of HRMM in clinical trials was not previously studied. We explored the definition of HRMM in completed phase III clinical trials. There is extreme v
Externí odkaz:
https://doaj.org/article/092efc3f964b4af8aef42ba95eaf4704
Publikováno v:
Clinical Hematology International, Vol 4, Iss 1-2, Pp 21-29 (2022)
Abstract The use of Bruton Tyrosine Kinase (BTK) inhibitors in Waldenström’s Macroglobulinemia (WM) is evolving. Ibrutinib, a first-generation BTK inhibitor, is currently approved for use in frontline and relapsed/refractory disease. Second-genera
Externí odkaz:
https://doaj.org/article/d64768bf7469431199d040434ee1ff4a
Publikováno v:
PLoS ONE, Vol 18, Iss 7, p e0289014 (2023)
Acute myeloid leukemia (AML) is a malignancy of the myeloid cells due to the clonal and malignant proliferation of blast cells. The etiology of AML is complex and involves environmental and genetic factors. Such genetic aberrations include FLT3, DNMT
Externí odkaz:
https://doaj.org/article/f487bd37b96c49f2b81f77ca035edc0e
Publikováno v:
Cancer Treatment and Research Communications, Vol 33, Iss , Pp 100643- (2022)
Immune checkpoint inhibitors (ICIs) have significantly advanced colorectal cancer treatment in recent years. Antibodies that target the proteins programmed cell death-1 (PD-1), programmed cell death-1 ligand 1 (PD-L1), and cytotoxic T-lymphocyte-asso
Externí odkaz:
https://doaj.org/article/77289718d9c0471ab99794dbd4b27196
Publikováno v:
Monday, April 24.
Autor:
Faris Jamal Abu Za'nouneh, Obada Ababneh, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, John D Shaughnessy, Fenghuang Zhan, Frits van Rhee, Samer Al Hadidi
Publikováno v:
Blood. 140:10116-10117
Autor:
Hassan Abushukair, Sebawe Syaj, Obada Ababneh, Aref Qarqash, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Frits van Rhee, Samer Al Hadidi
Publikováno v:
American journal of hematologyREFERENCES. 97(7)
Bruton tyrosine kinase inhibitors (BTKi) are important treatment options in Waldenström's macroglobulinemia (WM). Whether second-generation BTKi are associated with improved outcomes and/or better safety profile remains unclear. We did a systematic
Publikováno v:
Epilepsia. 63:1883-1884
Autor:
Shadi Hamouri, Nasr Alrabadi, Sebawe Syaj, Hassan Abushukair, Obada Ababneh, Leen Al-Kraimeen, Majd Al-Sous, Erich Hecker
Publikováno v:
Surgery today.
Extended resection for non-small cell lung cancer (NSCLC) with T4 left atrium involvement is controversial. We performed a systematic review and meta-analysis to evaluate the short- and long-term outcomes of this treatment strategy.We searched the Pu